Supramolecular Bioconjugates

The Portal is a joint project of MATTO and the MTTC. The development and implementation of the portal has been paid for by the MTTC, Beth Israel Deaconess Medical Center, Boston Biomedical Research Institute, Boston University, Brandeis University, Caritas St. Elizabeth's Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Northeastern University, The Schepens Eye Research Institute, and Tufts University.

Intellectual Property

ID:		94-33
IP Type:		Licensable Technology
Title:		Supramolecular Bioconjugates
Inventor:		Cantor, Charles R.
Summary:		This invention relates to supramolecular bioconjugates and to methods for assembling and utilizing supramolecular bioconjugates. Supramolecular bioconjugates comprise a plurality of first nucleic acids and a plurality of mediators wherein each mediator comprises a second nucleic acid complementary to a sequence within said plurality of first nucleic acids. Bioconjugates can be used to detect and isolate targets, to screen samples for targets such as antigens, to treat patients with multiple agents or to diagnose disorders in the form of a kit.
Tech Type:		Research Tools
URL:		http://ctf-fmfe.bu.edu/NoPDF.htm
Contact:		Harald Steltzer, cives@bu.edu, 617 358 4550
Organization:		Boston University

Display all intellectual properties for Cantor, Charles R.
Display all intellectual properties for Boston University